Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTEST CORP
Report date January 10, 2024 · Filed February 09, 2024
Section 16 reporting ended · disclosed 2024-02-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,476.056 |
Ending reported balance
After 2024-01-10 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2024-01-10 · Disposition to issuer · Disposed 425 · Balance 23,751.056 F1: Shares forfeited related to Mr. Nolen's April 29, 2020 time-vesting restricted stock award. Row 2 · 2024-01-10 · Disposition to issuer · Disposed 1,750 · Balance 22,001.056 F2: Shares forfeited related to Mr. Nolen's April 28, 2021 time-vesting restricted stock award. Row 3 · 2024-01-10 · Disposition to issuer · Disposed 2,958 · Balance 19,043.056 F3: Shares forfeited related to Mr. Nolen's April 28, 2022 time-vesting restricted stock award. Row 4 · 2024-01-10 · Disposition to issuer · Disposed 2,284 · Balance 16,759.056 F4: Shares forfeited related to Mr. Nolen's March 8, 2023 time-vesting restricted stock award. Row 5 · 2024-01-10 · Disposition to issuer · Disposed 2,283 · Balance 14,476.056 F5: Shares forfeited related to Mr. Nolen's March 8, 2023 performance-vesting restricted stock award. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.14 · Expires 2032-04-27 | Direct | 2,170 |
Reported balance
Holding disclosure · report date 2024-01-10 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 2,170 F6: This option is fully exercisable as of the date of this report. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.20 · Expires 2030-04-28 | Direct | 3,855 |
Reported balance
Holding disclosure · report date 2024-01-10 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 3,855 F6: This option is fully exercisable as of the date of this report. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.53 · Expires 2029-07-30 | Direct | 10,300 |
Reported balance
Holding disclosure · report date 2024-01-10 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 10,300 F6: This option is fully exercisable as of the date of this report. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares forfeited related to Mr. Nolen's April 29, 2020 time-vesting restricted stock award.
F2: Shares forfeited related to Mr. Nolen's April 28, 2021 time-vesting restricted stock award.
F3: Shares forfeited related to Mr. Nolen's April 28, 2022 time-vesting restricted stock award.
F4: Shares forfeited related to Mr. Nolen's March 8, 2023 time-vesting restricted stock award.
F5: Shares forfeited related to Mr. Nolen's March 8, 2023 performance-vesting restricted stock award.
F6: This option is fully exercisable as of the date of this report.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 10, 2024 Filed Feb 9, 2024 21:31 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 2,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-002768 · form4.xml · nonDerivative · entry 5 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,476.056 F5 · shares: Shares forfeited related to Mr. Nolen's March 8, 2023 performance-vesting restricted stock award. Read SEC document |
| January 10, 2024 Filed Feb 9, 2024 21:31 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 2,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-002768 · form4.xml · nonDerivative · entry 4 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,759.056 F4 · shares: Shares forfeited related to Mr. Nolen's March 8, 2023 time-vesting restricted stock award. Read SEC document |
| January 10, 2024 Filed Feb 9, 2024 21:31 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 2,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-002768 · form4.xml · nonDerivative · entry 3 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,043.056 F3 · shares: Shares forfeited related to Mr. Nolen's April 28, 2022 time-vesting restricted stock award. Read SEC document |
| January 10, 2024 Filed Feb 9, 2024 21:31 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 1,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-002768 · form4.xml · nonDerivative · entry 2 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,001.056 F2 · shares: Shares forfeited related to Mr. Nolen's April 28, 2021 time-vesting restricted stock award. Read SEC document |
| January 10, 2024 Filed Feb 9, 2024 21:31 UTC | INTEST CORP INTT · Entity 6590 | Disposition to issuerCommon Stock | 425 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-002768 · form4.xml · nonDerivative · entry 1 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,751.056 F1 · shares: Shares forfeited related to Mr. Nolen's April 29, 2020 time-vesting restricted stock award. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:29 UTC | INTEST CORP INTT · Entity 6590 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001062993-23-011398 · form4.xml · derivative · entry 5 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2031-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option, representing a right to purchase a total of 10,000 shares, vests in four equal annual installments commencing on April 28, 2022, which was the first anniversary of the date on which the option was granted. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:29 UTC | INTEST CORP INTT · Entity 6590 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001062993-23-011398 · form4.xml · derivative · entry 4 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,180 Underlying: Common Stock · 1,500 shares Expires 2032-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, representing a right to purchase a total of 14,680 shares, vests in four equal annual installments commencing on April 28, 2023, which was the first anniversary of the date on which the option was granted. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:29 UTC | INTEST CORP INTT · Entity 6590 | SaleCommon Stock | 7,597 | $21.14 | $160,615.77 |
DisclosureSEC source: 0001062993-23-011398 · form4.xml · nonDerivative · entry 3 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,249.418 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.98 to $21.26, inclusive. Mr. Nolen undertakes to provide inTEST Corporation, any security holder of inTEST Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:29 UTC | INTEST CORP INTT · Entity 6590 | Exercise / conversionCommon Stock | 5,000 | $13.13 | $65,650.00 |
DisclosureSEC source: 0001062993-23-011398 · form4.xml · nonDerivative · entry 2 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,846.418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:29 UTC | INTEST CORP INTT · Entity 6590 | Exercise / conversionCommon Stock | 1,500 | $8.14 | $12,210.00 |
DisclosureSEC source: 0001062993-23-011398 · form4.xml · nonDerivative · entry 1 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,846.418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2023 Filed May 2, 2023 20:37 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 107 | $19.00 | $2,033.00 |
DisclosureSEC source: 0001062993-23-009925 · form4.xml · nonDerivative · entry 3 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,346.418 F4 · shares: Shares withheld to cover tax withholding obligations upon the vesting of Mr. Nolen's April 29, 2020 time-vested restricted stock award. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:37 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 219 | $19.00 | $4,161.00 |
DisclosureSEC source: 0001062993-23-009925 · form4.xml · nonDerivative · entry 2 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,453.418 F3 · shares: Shares withheld to cover tax withholding obligations upon the vesting of Mr. Nolen's April 28, 2021 time-vested restricted stock award. Read SEC document |
| April 28, 2023 Filed May 2, 2023 20:37 UTC | INTEST CORP INTT · Entity 6590 | Tax withholdingCommon Stock | 247 | $19.00 | $4,693.00 |
DisclosureSEC source: 0001062993-23-009925 · form4.xml · nonDerivative · entry 1 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,672.418 F1 · shares: Shares withheld to cover tax withholding obligations upon the vesting of Mr. Nolen's April 28, 2022 time-vested restricted stock award. F2 · balance_after: Includes shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:41 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 3,936 | $0.00 Strike: $16.06 | $0.00 |
DisclosureSEC source: 0001062993-23-006635 · form4.xml · derivative · entry 3 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,936 Underlying: Common Stock · 3,936 shares Expires 2033-03-07 F4 · derivative.exercise_date: This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 8, 2024. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:41 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 2,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006635 · form4.xml · nonDerivative · entry 2 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,703.426 F3 · shares: These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 8, 2026 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 3,425. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 21:41 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 2,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006635 · form4.xml · nonDerivative · entry 1 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,420.426 F1 · shares: These restricted shares were granted pursuant to the Issuer's Fourth Amended and Restated 2014 Stock Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 8, 2024. F2 · balance_after: Includes shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:14 UTC | INTEST CORP INTT · Entity 6590 | GrantEmployee Stock Option (right to buy) · Derivative | 14,680 | $0.00 Strike: $8.14 | $0.00 |
DisclosureSEC source: 0001036262-22-000010 · primary_doc.xml · derivative · entry 2 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,680 Underlying: Common Stock · 14,680 shares Expires 2032-04-27 F3 · derivative.exercise_date: The option was issued pursuant to the Stock Plan and will vest 25% annually commencing on April 28, 2023. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:14 UTC | INTEST CORP INTT · Entity 6590 | GrantCommon Stock | 3,944 | $0.00 | $0.00 |
DisclosureSEC source: 0001036262-22-000010 · primary_doc.xml · nonDerivative · entry 1 Nolen Scott Eric · CIK 0001918820 · Division Pres-Process Tech 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,952.305 F1 · shares: The shares acquired are restricted shares issued pursuant to the Issuer's Third Amended and Restated 2014 Stock Plan (the "Stock Plan") and will vest 25% annually commencing on April 28, 2023. F2 · balance_after: Includes shares acquired pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.